Appointment of Dr. Naser Hiraad as CEO of AryoGen Pharmed

Following a decision by the Board of Directors of AryoGen Pharmed, Dr. Naser Hiraad has been appointed as the company’s new Chief Executive Officer (CEO).

Dr. Hirad holds a Doctor of Pharmacy (Pharm.D.) degree and previously served as the CEO of Nivad Pharmed Salamat as well as the Deputy Director of Planning at the Department of Medicines and Controlled Substances of the Food and Drug Administration.

We are confident that, with his extensive experience, expertise, and forward-looking vision, a new chapter of growth, innovation, and organizational excellence will begin, further strengthening the company’s path toward sustainable development.

We would also like to sincerely express our appreciation to Mr. Mohammad Saffarioun for his years of dedicated efforts and committed leadership. His valuable contributions, support, and responsible approach have played an important role in shaping the company’s growth journey.

The Public Relations Department of AryoGen Pharmed wishes both distinguished colleagues continued success in their future endeavors and hopes that, through the continued collaboration and dedication of all employees, the company will take more effective steps in serving the community and advancing the pharmaceutical industry in this new chapter.